NCT00684528View on ClinicalTrials.gov

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

PHASE3UnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2012

Conditions
Diabetes Type 2
Interventions
DRUG

Metformin 1500 mg daily

500 mg thrice daily

DRUG

Metformin + Janufer (Janumet)

Titration up to 1500/150 mg daily

Trial Locations (1)

62098

RECRUITING

Clalit Health services center, Tel Aviv

Sponsors

Collaborators (1)

Clalit Health Services
All Listed Sponsors
collaborator

Clalit Health Services

OTHER

lead

Meir Medical Center

OTHER

NCT00684528 - A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin | Biotech Hunter | Biotech Hunter